Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Targeted therapies in epithelial ovarian cancer.

Dean E, El-Helw L, Hasan J.

Cancers (Basel). 2010 Feb 23;2(1):88-113. doi: 10.3390/cancers2010088.

2.

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

El-Helw LM, Hancock BW.

Future Oncol. 2009 May;5(4):445-53. doi: 10.2217/fon.09.13. Review.

PMID:
19450173
3.

Small-cell lung cancer: 8 years experience of a single multidisciplinary team.

El-Helw LM, Rogers TK, Hatton MQ.

J Oncol. 2008;2008:150760. doi: 10.1155/2008/150760. Epub 2008 Oct 16.

4.

Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

El-Helw LM, Hancock BW.

Expert Opin Investig Drugs. 2007 Oct;16(10):1683-91. Review.

PMID:
17922631
5.

Treatment of metastatic gestational trophoblastic neoplasia.

El-Helw LM, Hancock BW.

Lancet Oncol. 2007 Aug;8(8):715-24. Review.

PMID:
17679081
6.

High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumours.

El-Helw LM, Naik JD, Chester JD, Joffe JK, Selby PJ, Coleman RE.

BJU Int. 2006 Sep;98(3):519-25.

Supplemental Content

Loading ...
Support Center